Revelation Biosciences In... (REVB)
NasdaqCM: REVB
· リアルタイム株価 · USD
1.19
+0.08 (7.21%)
終値時点： Aug 18, 2026, 3:59 PM
Revelation Biosciences Inc. (REVB) Stock Price, Analysis & Data
7.21% (1D)
REVBについて
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the ...
企業情報の全文アナリスト予想
2件のアナリスト評価によると、REVB株の平均レーティングは「Strong Buy」です。12か月後の目標株価は17.75で、直近株価から1391.6%の上昇余地となります。
株価予想決算サプライズ
Revelation BiosciencesはAug 6, 2026に四半期決算を発表しました：